Leukemia & Lymphoma Society Initiatives to Halt Early Stage Myeloid Blood Cancers Fourth in ASH 2014 Series by David Wallace PV Reporter sits down with Dr Lee Greenberger, Chief Scientific Officer with LLS, to discuss initiatives to halt early stage myeloid blood cancers (MPNs & MDS). LLS has grants with Dana Farber to better understand […]
Dr Heinz Gisslinger Enlightens us – Treating MPNs with Interferon for 30 Years
AOP 2014 – The Next Generation Interferon Second in ASH 2014 Series by David Wallace Dr Heinz Gisslinger from Vienna, Austria is a pioneer in treating MPN patients with Interferon (IFN). PV Reporter sits down with Dr Gisslinger at ASH 2014 to discuss the history of Interferon treatment in MPNs, as well as AOP 2014. […]
ASH 2014 Series Coverage
by David Wallace PV Reporter covering the American Society of Hematology (ASH) 2014 conference in a series format For me personally, highlights go beyond the research that was presented (ASH 2014 Outside the Box, addresses that in detail). It was about meeting friends…old and new (in person), attending the MPN Heroes Awards Presentation, the excitement […]
Polycythemia Vera Pre-diagnosis Patient Report
Publisher’s Intro by David Wallace As a certified, red-blooded JAK2 positive Polycythemia Vera (PV) patient, I have always been fascinated by the events leading up to a PV diagnosis. By sharing our stories, perhaps we offer “a dose of comfort” to the new or recently diagnosed. When they read of struggles that other patient’s experience, […]
Leukemia & Lymphoma Society Launches New Program to Halt Progression of Myeloid Blood Cancers
The LLS and Janssen Research & Development, LLC have committed $1.7 million for the initiative White Plains, NY (October 28, 2014) – The Leukemia & Lymphoma Society has initiated a program to fund research projects seeking to better understand and, ultimately, stop progression of certain types of blood cancers from early-stage malignancies to much more […]
MPN Clinical Trial updates from Geron and Promedior
Geron announces removal of Full Clinical Hold on Imetelstat The full clinical hold on Geron’s sole pipeline candidate, investigation new drug (IND), Imetelstat, has been lifted by the FDA. The company does not intend to conduct further studies or develop imetelstat for the treatment of essential thrombocythemia (ET) or polycythemia vera (PV). The development plan […]
PV Reporter introduces new Mobile App
MPN Information on Your Phone PV Reporter has introduced a new mobile app that you can download to your phone (iOS). The app provides instant access to multiple pages on our website (MPN Search, Specialists, Blog, Resources), Facebook page, Twitter page, PV Tracker Tool, email contact information and the ability to share the app via […]
Tips on How to treat your Chronically Ill Friend
Publisher’s Note I discovered the article “10 Tips of How to be a Friend to a Chronically Ill Sufferer” on Facebook and found it to be relevant for many MPN patients. I asked Mary McGregor, the author, if I could feature it on PV Reporter and she agreed. I like her self-described “rant” style, it […]
A key role for lymphoid cells in the pathology of myeloproliferative neoplasm
Publisher’s Note In early July, we reported The MPN Research Foundation and LLS granted $1 million research funding for MPNs. Dr Angela Fleischman has been a key contributor to PV Reporter and was one of the MPN Challenge award winners. I asked her for a description of the research they will be working on and she […]
High levels of Inflammation disrupt normal blood formation potentially leading to leukemia
Indiana University researchers identify events causing bone marrow inflammation leading to blood disorders Like a line of falling dominos, a cascade of molecular events in the bone marrow produces high levels of inflammation that disrupt normal blood formation and lead to potentially deadly disorders including leukemia. “It has been known for years that there are […]
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 21
- Next Page »
